Onconetix, Inc.
ONCO
$0.0761
-$0.0039-4.88%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -38.11% | -3.53% | 111.58% | 118.89% | 58.44% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -31.98% | -10.41% | 50.85% | 67.99% | 15.98% |
| Operating Income | 41.05% | 32.79% | -26.26% | -66.18% | -15.98% |
| Income Before Tax | 27.36% | -107.65% | -294.86% | -594.97% | -38.28% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 28.42% | -108.39% | -290.59% | -594.58% | -38.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 28.42% | -108.39% | -290.59% | -594.58% | -38.28% |
| EBIT | 41.05% | 32.79% | -26.26% | -66.18% | -15.98% |
| EBITDA | 45.57% | 39.15% | -19.08% | -65.08% | -15.99% |
| EPS Basic | 75.99% | -49.34% | -180.59% | -490.84% | -13.16% |
| Normalized Basic EPS | 79.59% | 46.55% | -0.47% | 45.15% | -2.79% |
| EPS Diluted | 75.99% | -49.34% | -180.59% | -490.84% | -13.16% |
| Normalized Diluted EPS | 79.59% | 46.55% | -0.47% | 45.15% | -2.79% |
| Average Basic Shares Outstanding | 198.20% | 39.53% | 39.19% | 17.57% | 22.18% |
| Average Diluted Shares Outstanding | 198.20% | 39.53% | 39.19% | 17.57% | 22.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |